openPR Logo
Press release

Cancer Biomarkers Market Outlook to 2027 by Top Competitors Bio-Rad Laboratories, QIAGEN, Illumina, GENERAL ELECTRIC COMPANY, bioMérieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Creative Diagnostics, Hologic and Quest Diagnostics

02-14-2019 04:43 AM CET | Science & Education

Press release from: The Insight Partners

Cancer Biomarkers Market

Cancer Biomarkers Market

Worldwide Cancer Biomarkers Market Analysis to 2027 is a specialized and in-depth study of the global industry with a focus on the global market trend. The report aims to provide an overview of global Cancer Biomarkers market with detailed market segmentation by product/application and geography. The global Cancer Biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Cancer Biomarkers players and offers key trends and opportunities in the market.

Rise in the number of cancer cases as well as increasing research and development activities is anticipated to drive the growth of the cancer biomarkers market. Rising awareness regarding personalized medicine is expected to offer significant growth opportunities in the market in the coming years.

The key players operating in the cancer biomarkers market include, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., QIAGEN, Illumina, Inc., GENERAL ELECTRIC COMPANY, bioMérieux, Inc., Creative Diagnostics, Hologic Inc., and Quest Diagnostics among others.

Get sample PDF copy at: http://bit.ly/2TPvwBs

Cancer biomarkers are the molecules that help in the diagnosis as well as the treatment of various forms of cancer. These molecules are produced by the cancer tissue or by other cells in the body in response to cancer. These molecules can be monitored by obtaining samples such as, blood, stool, urine, tumor tissue, or other tissues or bodily fluids.

The Cancer Biomarkers Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

North America is expected to contribute to the largest share in the cancer biomarkers market in the coming years, owing to rising incidence of cancer. Asia Pacific is expected to witness significant growth during the forecast period, due to increase in the number of R&D activities being conducted in the field of cancer therapy.

Cancer Biomarkers Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2017 – 2027, considering 2017 as the base year and 2018 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

Inquire for Discount at: http://bit.ly/2TPKpE6

Reason to Buy

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Cancer Biomarkers Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Cancer Biomarkers Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market Outlook to 2027 by Top Competitors Bio-Rad Laboratories, QIAGEN, Illumina, GENERAL ELECTRIC COMPANY, bioMérieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Creative Diagnostics, Hologic and Quest Diagnostics here

News-ID: 1586661 • Views: 835

More Releases from The Insight Partners

De-oiled Lecithin Market: Growth Factors, Applications and Regional Analysis and …
The Insight Partners’ report on the De-oiled Lecithin Market aims at developing a better understanding of the De-oiled Lecithin industry through qualitative and quantitative analysis of the key market parameters. The De-oiled Lecithin market is classified on the basis of form, source, and application, and the market is evaluated in terms of growth, value, and volume across five major geographical regions. The report aims to provide an overview of the de-oiled
Wearable Medical Devices Market Worth to be US$ 23,310.9 Million and anticipated …
The latest addition of Wearable Medical Devices market 2027 to The Insight Partners’ store offers major insights on the market size, growth rate, and estimates during the forecast period. It effectively evaluates the market based on device type and application and provides global perspective concerning five major geographical regions. The report would be of an interest to various stakeholders operating in the wearable medical devices market. These stakeholders include healthcare
Automotive Logistics Market Research Report by Geographical Analysis and Forecas …
According to a new market study entitled "Automotive Logistics Market to 2027 - Global Analysis and Forecasts by Deployment Type (On-Premise and Cloud) and Industry Vertical (BFSI, Healthcare & Life Sciences, Retail & Consumer Goods, Manufacturing, Travel & Hospitality, IT & Telecommunication, Media & Entertainment, and Others) and Geography, "explains the report, explaining the key drivers of this growth and highlighting key market players and their evolution. The report factors
Fetal Monitors Market Analysis And Growth Forecast By Applications, Sales, Size, …
To achieve success in the competition of global market place, going for this global Fetal Monitors market research report is the key. The report strategically analyses the growth trends and future prospects. Moreover, this Fetal Monitors market report also provides strategic profiling of top players in the Fetal Monitors industry, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. Further, it presents the company profile, product

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and